Diagnostics Market Research Reports & Industry Analysis

The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.

New Diagnostics Industry Reports Produced by Industry Experts

To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.

What Are the Benefits of Using MarketResearch.com?

  • At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
  • We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
  • Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
  • With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
...Show More ...Show Less


Diagnostics Industry Research & Market Reports

  • COVID-19 Testing

    ... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More

  • STD Testing

    ... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More

  • Hemostasis Diagnostics

    ... CAGR of 4.8% over the analysis period 2024-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the end of ... Read More

  • Image Guided Surgery Devices

    ... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Cardiac Surgery, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Million by the ... Read More

  • Tuberculosis Testing

    ... CAGR of 4.9% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the end of the analysis period. ... Read More

  • Veterinary Hematology Analyzers

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More

  • Veterinary Molecular Diagnostics

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More

  • Lung Cancer Diagnostics

    ... at a CAGR of 7.8% over the analysis period 2024-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.3 Billion by the end of ... Read More

  • Toxicology Testing Services

    ... at a CAGR of 8.4% over the analysis period 2024-2030. In Vivo Method, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$10.2 Billion by the end ... Read More

  • Blood Banking and Blood Products

    ... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More

  • Fluoroscopy and Mobile C-Arms

    ... 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Fluoroscopy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end ... Read More

  • Hemoglobin A1C (HbA1C) Testing

    ... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach ... Read More

  • Molecular Diagnostics

    ... CAGR of 9.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$16.0 Billion by the end of the ... Read More

  • Analytical Laboratory Services

    ... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end of ... Read More

  • Anatomic Pathology

    ... CAGR of 5.8% over the analysis period 2024-2030. Disease Diagnostics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$53.0 Billion by the end of the analysis ... Read More

  • Blood Transfusion Devices

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end ... Read More

  • Blood Screening

    ... CAGR of 5.5% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end of the ... Read More

  • Breast Imaging Technologies

    ... at a CAGR of 5.2% over the analysis period 2024-2030. Ionizing Technologies, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$3.3 Billion by the end of ... Read More

  • Breast Lesion Localization

    ... at a CAGR of 4.5% over the analysis period 2024-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of ... Read More

  • Carrier Screening

    ... CAGR of 15.6% over the analysis period 2024-2030. Genetic Disorders, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$3.0 Billion by the end of the analysis ... Read More

  • Cell Proliferation Kits

    ... at a CAGR of 5.5% over the analysis period 2024-2030. Pharma & Biotech Companies, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$394.2 Million by the ... Read More

  • Contrast Injectors

    ... CAGR of 4.5% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$470.8 Million by the end of the analysis period. ... Read More

  • Dental Digital X-ray

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Extraoral, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.2 Billion by the end of the ... Read More

  • Enteric Disease Testing

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Bacterial Enteric Disease, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end ... Read More

  • Histology and Cytology

    ... at a CAGR of 14.4% over the analysis period 2024-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$50.6 Billion by the end of the ... Read More

Cookie Settings